ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
65 hedge funds and large institutions have $183M invested in ChemoCentryx, Inc. in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 8 closing their positions.
1,021% more call options, than puts
Call options by funds: $2.89M | Put options by funds: $258K
49% more capital invested
Capital invested by funds: $123M → $183M (+$60M)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
2% more funds holding
Funds holding: 64 → 65 (+1)
5% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.11M |
| 2 |
Millennium Management
New York
|
+$1.95M |
| 3 |
First Manhattan
New York
|
+$1.38M |
| 4 |
Goldman Sachs
New York
|
+$776K |
| 5 |
BACM
Blue Arrow Capital Management
New York
|
+$740K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.04M |
| 2 |
BC
Broadfin Capital
New York
|
-$3.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.18M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$532K |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$476K |
CCXI Hedge Fund Activity: Q4 2014 in Review
65 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2014, worth a combined $183M — up 49% from $123M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CCXI positions and 8 closed out — a net gain of 3 holders — while 20 added to existing stakes and 19 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $2.11M. The largest seller was Balyasny Asset Management, cutting an estimated $5.04M.
- 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2014, up from 64 in Q3 2014.
- Funds reported $183M of ChemoCentryx, Inc. stock for Q4 2014, up 49% quarter-over-quarter.
- 11 funds opened new ChemoCentryx, Inc. positions in Q4 2014 and 8 closed out, a net change of +3 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2014 was Fidelity Investments, an estimated $2.11M added.
- The largest ChemoCentryx, Inc. seller in Q4 2014 was Balyasny Asset Management, an estimated $5.04M sold.
Based on aggregated 13F filings for Q4 2014.